Bio-Rad Laboratories (BIO) Earnings Date, Estimates & Call Transcripts $246.31 -3.34 (-1.34%) As of 07/18/2025 03:59 PM Eastern Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Bio-Rad Laboratories Earnings Summary Bio-Rad Laboratories announced Q1 2025 earnings on May 1, 2025, reporting an EPS of $2.54, which topped the consensus estimate of $1.73 by $0.81. Quarterly revenue fell 4.2% year-over-year to $585.40 million, above analysts' expectations of $573.01 million. With a trailing EPS of -$76.20, Bio-Rad Laboratories' earnings are expected to grow 15.17% next year, from $10.81 to $12.45 per share. Upcoming Q2 Earnings DateJul. 31After Market ClosesConfirmedConsensus EPS (May. 1) $1.73 Actual EPS (May. 1) $2.54 Beat By $0.81 Actual Revenue (May. 1) $585.40MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Press Release (8-K) Quarterly Report (10-Q)BIO Upcoming EarningsBio-Rad Laboratories' Q2 2025 earnings is scheduled for Thursday, July 31, 2025, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get Bio-Rad Laboratories Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bio-Rad Laboratories and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBIO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BIO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Bio-Rad Laboratories Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20251$1.98$1.98$1.98Q2 20251$1.93$1.93$1.93Q3 20251$2.20$2.20$2.20Q4 20251$2.57$2.57$2.57 FY 2025 4 $8.68 $8.68 $8.68 Q1 20261$2.79$2.79$2.79Q2 20261$2.46$2.46$2.46Q3 20261$2.49$2.49$2.49Q4 20261$2.78$2.78$2.78 FY 2026 4 $10.52 $10.52 $10.52 Q1 20271$2.45$2.45$2.45Q2 20271$1.95$1.95$1.95 Bio-Rad Laboratories Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 7/31/2025(Confirmed)-------5/1/2025Q1 2025$1.73$2.54+$0.81$2.29$573.01M$585.40M2/13/2025Q4 2024$2.86$2.90+$0.04-$25.57$679.75M-10/30/2024Q3 2024$1.16$2.01+$0.85-$19.32$628.18M$649.70M8/1/2024Q2 2024$2.12$3.11+$0.99$82.48$645.79M$638.50M5/7/2024Q1 2024$2.04$2.29+$0.25-$8.87$619.09M$610.82M2/15/2024Q4 2023$2.93$3.10+$0.17-$5.94$685.00M$681.18M10/26/2023Q3 2023$2.87$2.33 -$0.54$1.02$689.50M$632.10M8/3/2023Q2 2023$2.55$3.00+$0.45$45.59$697.96M$681.10M Bio-Rad Laboratories Earnings - Frequently Asked Questions When is Bio-Rad Laboratories' earnings date? Bio-Rad Laboratories has confirmed that its next quarterly earnings data will be published on Thursday, July 31st, 2025. Learn more on BIO's earnings history. What guidance has Bio-Rad Laboratories issued on next quarter's earnings? Bio-Rad Laboratories updated its FY 2025 earnings guidance on Thursday, May, 1st. The company issued revenue guidance of $2.5 billion-$2.6 billion, compared to the consensus revenue estimate of $2.6 billion. Did Bio-Rad Laboratories beat their earnings estimates last quarter? In the previous quarter, Bio-Rad Laboratories (NYSE:BIO) reported $2.54 earnings per share (EPS) to beat the analysts' consensus estimate of $1.73 by $0.81. Learn more on analysts' earnings estimate vs. BIO's actual earnings. How can I listen to Bio-Rad Laboratories' earnings conference call? The conference call for Bio-Rad Laboratories' latest earnings report can be listened to online. Listen to Conference Call How can I read Bio-Rad Laboratories' conference call transcript? The conference call transcript for Bio-Rad Laboratories' latest earnings report can be read online. Read Transcript How much revenue does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded annual revenue of $2.57 billion. How much profit does Bio-Rad Laboratories generate each year? Bio-Rad Laboratories (NYSE:BIO) has a recorded net income of -$1.84 billion. BIO has generated -$76.20 earnings per share over the last four quarters. What is Bio-Rad Laboratories' EPS forecast for next year? Bio-Rad Laboratories' earnings are expected to grow from $10.81 per share to $12.45 per share in the next year, which is a 15.17% increase. More Earnings Resources from MarketBeat Related Companies MTD Earnings WAT Earnings ILMN Earnings TECH Earnings CRL Earnings BRKR Earnings PACB Earnings HBIO Earnings TMO Earnings A Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Netflix Q2 2025 Earnings: What Investors Need to KnowHow Goldman Sachs Earnings Help You Strategize Your PortfolioCitigroup Earnings Could Signal What’s Next for Markets3 Analysts Set $600 Target Ahead of Microsoft EarningsTesla: 2 Plays Ahead of Next Week's Earnings ReportFastenal Surges After Earnings Beat, Tariff Risks Loom3 Catalysts Converge on Intel Ahead of a Critical Earnings Report This page (NYSE:BIO) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts